Navigation Links
Increasing Breast Density Significantly Impacts Breast Cancer Screening Performance
Date:1/30/2017

WELLINGTON, New Zealand, Jan. 30, 2017 /PRNewswire/ -- In the first large-scale study of its kind, Dutch researchers demonstrated a strong linear relationship between decreased screening performance and volumetric breast density.  Involving more than 110,000 mammograms from the Dutch Breast Screening Program (Foundation of Population Screening Mid-West), the study showed that increasing volumetric breast density, automatically measured by Volpara®Density™ software, impacts mammography performance measures, such as sensitivity and the rates of recall, false positives, and interval cancers.

The study, "Volumetric breast density affects performance of digital screening mammography," was recently published in Breast Cancer Research and Treatment (DOI: 10.1007/s10549-016-4090-7) and was carried out in the EU-funded ASSURE project  The results suggest that, since fully automated measurements of breast density have much higher reproducibility than visual assessment, this automatic method could help with implementing density-based supplemental screening.

In the study, Dr Carla van Gils and a team of researchers from the Netherlands examined screening performance in the Dutch Screening Program using a consecutive series of 111,898 digital mammograms from 53,239 women (age 50–75 years). Volumetric breast density was automatically assessed using VolparaDensity software, which automatically generates an objective measurement of volumetric breast density.

"There have been several studies that have demonstrated the impact of breast density on the sensitivity of mammography, including a recent study published in the American Journal of Roentgenology1 that showed a strong linear relationship between volumetric breast density and sensitivity.  However, this is the first large-scale study to also demonstrate a strong relationship between volumetric density and other screening performance measures like recall rate, false positives or interval cancers," said Dr van Gils.  "With the high reproducibility of the automatic VolparaDensity software, this could help with evaluating risk and better inform clinical decisions about adjunctive screening options based on women's specific density and other risk factors."

The study included 667 screen-detected and 234 interval cancers. Of all the tumors, 84.3% were invasive cancers.  Mammographic sensitivity was 85.7%, 77.6%, 69.5%, and 61.0% across VDG categories 1-4, respectively.  Increasing breast density showed a strong linear relationship to all screening performance measures, except positive predictive value.  The rates for recalls, false positives, and total and interval breast cancers in higher breast density categories were greater than those in lower density categories. Results demonstrated that a woman was nearly seven times more likely (4.4/1000 examinations versus 0.7/1000) to have an interval cancer if her breasts were extremely dense (VDG4) versus very fatty (VDG1) and approximately twice as likely (23.8/1000 examinations versus 11.2/1000) to have a false-positive if they were extremely dense (VDG4) versus very fatty (VDG1).

According to Dr van Gils, another interesting finding is the relationship between cancer type (in situ or invasive), breast density and detection mode (screen-detected or interval).  When only invasive breast cancer was taken into account, the difference in sensitivity between the density categories was even more pronounced.

"This indicates that the detection of invasive breast cancers in screening is hampered to a larger extent than the detection of in situ breast cancers. A possible explanation for this is that the visibility of microcalcifications is not hampered as much in dense tissue as the visibility of invasive breast cancers," added Dr van Gils.  "Studying this relationship further could be very important as we further develop our understanding of the effectiveness of screening."

About Volpara Solutions

Founded with the goal of helping radiologists give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Volpara Health Technologies Limited of New Zealand (formerly Matakina Technology). Available in most markets where breast cancer screening is commonplace, VolparaDensity provides an objective volumetric measure of breast density from both digital mammography and tomosynthesis data. VolparaDensity software is part of a suite of quantitative breast imaging tools built on the Volpara Solutions algorithm that allows for personalized measurements of density, patient-specific x-ray dose, breast compression, breast positioning, and other factors designed to provide critical insight for breast imaging workflow. For more information, visit www.volparasolutions.com.

1 "Using volumetric breast density to quantify the potential masking risk of mammographic density," published in the American Journal of Roentgenology (AJR) (DOI:10.2214/AJR.16.16489)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/increasing-breast-density-significantly-impacts-breast-cancer-screening-performance-300398295.html


'/>"/>
SOURCE Volpara Solutions
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth
2. Increasing Demand from End-user Applications Boosts Asia-Pacific Antimicrobial Coatings Market, Finds Frost & Sullivan
3. Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics
4. Increasing Affluence and Legislative Reforms are Transforming Polands Pharmaceutical Market, Which Holds Strategic Importance for Multinational Companies
5. The Systemic Lupus Erythematosus Market Will Grow Dramatically Over the Next Decade, Increasing from Approximately $900 Million in 2012 to $4 Billion in 2022
6. First Financial Expands into Canada to Meet Increasing Demand for its Leasing Solutions
7. Pressure Relief Devices Market to 2019 - Increasing Focus on Pressure Ulcer Prevention and Quality of Care to Drive Growth: Industry Analysis, Size, Share, Growth, Trends and Forecast Now Available at MarketResearchReports.biz
8. Increasing Use of Allergans Botox and the Launch of Novel Nontriptan Products Will Be Key Drivers of Migraine Market Growth Through 2022
9. Surveyed Oncologists Indicate that the Use of Biomarker Testing is Increasing Rapidly in Non-Small-Cell Lung Cancer in China and South Korea
10. Despite Increasing Cost Sensitivity of EU5 Payers, Sofosbuvir and Simeprevir are Poised to Reshape the Hepatitis C Virus Market by End of 2015
11. The Asthma Drug Market Will Remain Relatively Flat, Increasing Slightly from $15.3 Billion in 2012 to $16.2 Billion in 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Texas , Oct. 11, 2017  Caris Life ... focused on fulfilling the promise of precision medicine, today ... has joined Caris, Precision Oncology Alliance™ (POA) as its ... cancer centers, the St. Jude Crosson Cancer Institute will ... advance the use of tumor profiling, making cancer treatment ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... As health professionals ... known as “patient engagement.” The patient is doing more than filling out a survey; ... , “There is an increasing emphasis in health care and research on the importance ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):